Get the Stockscreener App
12.50
3.99%
0.4799
Envveno Medical Corporation stock is traded at $12.50, with a volume of 5,008.
It is up +3.99% in the last 24 hours and up +34.41% over the past month.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
See More
Previous Close:
$12.02
Open:
$11.78
24h Volume:
5,008
Relative Volume:
0.26
Market Cap:
$8.13M
Revenue:
-
Net Income/Loss:
$-24.05M
P/E Ratio:
-5.8139
EPS:
-2.15
Net Cash Flow:
$-17.78M
1W Performance:
+15.90%
1M Performance:
+34.41%
6M Performance:
-54.56%
1Y Performance:
-87.51%
1-Day Range:
$11.78
$12.50
1-Week Range:
$10.21
$12.85
52-Week Range:
$8.67
$196.70
Envveno Medical Corporation Stock (NVNO) Company Profile
Name
Envveno Medical Corporation
Sector
Industry
Phone
949-261-2900
Address
70 DOPPLER, IRVINE
Compare NVNO vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
12.40 | 7.88M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
110.21 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
343.37 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.00 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.86 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.64 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Envveno Medical Corporation Stock (NVNO) Latest News
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - Independent Mail
NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives - The Manila Times
Reviewing Pressure BioSciences (OTCMKTS:PBIO) & enVVeno Medical (NASDAQ:NVNO) - Defense World
NVNO SEC FilingsEnvveno Medical Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
NVNO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can enVVeno Medical Corporation maintain sales growthQuarterly Profit Summary & Daily Growth Stock Tips - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
enVVeno Medical (NVNO) investor urges halt to trials, strategic review - Stock Titan
enVVeno Medical Announces Reverse Stock Split - Press & Sun-Bulletin
Perceptive funds hold 2.05M enVVeno (NVNO) shares and warrants - Stock Titan
NVNO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Strategic Investor Acquires Significant Stake in enVVeno Medical - AD HOC NEWS
Investor Braeden Lichti discloses 5.05% enVVeno (NVNO) ownership stake - Stock Titan
Aug Analyst Calls: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Risk Factors & Short-Term High Return Ideas - baoquankhu1.vn
Head to Head Analysis: LENSAR (NASDAQ:LNSR) versus enVVeno Medical (NASDAQ:NVNO) - Defense World
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - The Northwest Florida Daily News
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - DelmarvaNow.com
enVVeno Medical Regains Nasdaq Compliance, Supports 2026 Plans - The Globe and Mail
EnVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - News Channel Nebraska Southeast
enVVeno Medical regains Nasdaq compliance, reports $28 million cash By Investing.com - Investing.com Nigeria
enVVeno Medical regains compliance with Nasdaq minimum bid price rule - TipRanks
enVVeno Medical Regains Nasdaq Compliance - Orange County Business Journal
enVVeno Medical regains Nasdaq compliance, reports $28 million cash - Investing.com
Bank Watch: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Performance Recap & Smart Investment Allocation Tips - baoquankhu1.vn
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Green Bay Press-Gazette
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Breakout Zone: Why is Pliant Therapeutics Inc stock going upJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Volume Report: Will enVVeno Medical Corporation benefit from seasonalityShort Setup & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Envveno Medical Corporation Stock (NVNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
1.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):